DNA Capital has returned to lead a $59.5m round for the Qualcomm Ventures-backed digital prescription startup.
Memed, a Brazil-based digital prescription service backed by mobile semiconductor technology developer Qualcomm, has received R$300m ($59.5m) in a round led by investment partnership DNA Capital, Baguete has reported.
DNA Capital invested through a vehicle created specifically for Memed, and was joined by four other investors including unnamed family offices and sovereign wealth funds.
Founded in 2012, Memed has built an online platform that helps healthcare providers access their patients’ electronic medical records and databases through an application programming interface,…